Literature DB >> 31714407

Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies: Erratum.

.   

Abstract

Entities:  

Year:  2020        PMID: 31714407      PMCID: PMC7566290          DOI: 10.1097/ICO.0000000000002221

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   3.152


× No keyword cloud information.
  1 in total

1.  Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies.

Authors:  Ranjan Malhotra; Douglas K Devries; Jodi Luchs; Alan Kabat; Barry A Schechter; Bridgitte Shen Lee; Lee Shettle; Robert Smyth-Medina; Abayomi Ogundele; Charles Darby; Jason Bacharach; Paul Karpecki
Journal:  Cornea       Date:  2019-10       Impact factor: 2.651

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.